Toxins produced by highly specialized stem cells work to treat brain cancer. Researchers from Harvard Medical School are the engineers behind these killer stem cells.

The Centers for Medicare & Medicaid Services has relaunched its Open Payment website. The general impression is that the new site is worlds easier to navigate than its original launch.

A new and tiny camera steals from the sight of the powerful, all-seeing mantis shrimp in order to detect cancers that we currently cannot. The new and rather simple system relies on polarized light, which these shrimps can see in spades, to create a whole new dimension of cancer imaging, according to this report from Smithsonian.

The National Cancer Institute has mounted a search for people who are dramatic outliers in their response to cancer therapies in an effort to improve treatments for common malignancies.

Almost 50 percent of devices and 40 percent of medications administered in the U.S. are produced outside its borders. Around 80 percent of the producers of active pharmaceutical ingredients are internationally based and the speed of global research and commerce is swiftly changing. Clearly, the regulatory framework needs to keep up. With that in mind, the FDA is setting new priorities for the coming years. An official document has been drawn up by the FDA to that effect.

The Radiological Society of North America (RSNA) announced today that it has received an additional $1.27 million of funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to support research by the Quantitative Imaging Biomarkers Alliance (QIBA). 

Yet another risk factor for neurodegenerative disease has cropped up in recent studies: Worry among older women. Research conducted at the University of Gothenburg in Sweden provided a score on the scale of neuroticism for 800 women in mid-life and evaluated any potential links to Alzheimer's. Those who peaked on the anxiety scale were two times as likely to develop the disease.

An analysis of genetic biomarkers from Genetic Engineering & Biotechnology explains the differences between predictive and prognostic characteristics and provides a perspective on the current landscape of research and development for a number of key assays.